107
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Preliminary Screening of a Familial Tuberous Sclerosis Complex Pathogenic Gene

, , , , , & show all
Pages 5247-5252 | Published online: 26 May 2022

References

  • Northrup H, Krueger DA, Northrup H. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international Tuberous Sclerosis Complex consensus conference. Pediatr Neurol. 2013;49(4):243–254. doi:10.1016/j.pediatrneurol.2013.08.001
  • Peron A, Northrup H. Tuberous sclerosis complex. Am J Med Genet C Semin Med Genet. 2018;178(3):274–277. doi:10.1002/ajmg.c.31657
  • Okamoto SI, Prikhodko O, Pina-Crespo J, et al. NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model. Neurobiol Dis. 2019;127:390–397. doi:10.1016/j.nbd.2019.03.029
  • Wu S, Guo Y, Liu C, et al. Identification of a de novo TSC2 variant in a Han-Chinese family with tuberous sclerosis complex. J Chin Med Assoc. 2021;84(1):46–50. doi:10.1097/JCMA.0000000000000455
  • Dodd KM, Dunlop EA. Tuberous sclerosis–A model for tumour growth. Semin Cell Dev Biol. 2016;52:3–11. doi:10.1016/j.semcdb.2016.01.025
  • Feliciano DM. The neurodevelopmental pathogenesis of Tuberous Sclerosis Complex (TSC). Front Neuroanat. 2020;14:39. doi:10.3389/fnana.2020.00039
  • Wang MX, Segaran N, Bhalla S, et al. Tuberous sclerosis: current update. Radiographics. 2021;41(7):1992–2010. doi:10.1148/rg.2021210103
  • Li Y, Cao J, Chen M, et al. Abnormal neural progenitor cells differentiated from induced pluripotent stem cells partially mimicked development of TSC2 neurological abnormalities. Stem Cell Rep. 2017;8(4):883–893. doi:10.1016/j.stemcr.2017.02.020
  • Tyburczy ME, Wang JA, Li S, et al. Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex. Hum Mol Genet. 2014;23:2023–2029. doi:10.1093/hmg/ddt597
  • Gao S, Wang Z, Xie Y. Two novel TSC2 mutations in pediatric patients with tuberous sclerosis complex: case report. Medicine. 2018;97(29):e11533. doi:10.1097/MD.0000000000011533
  • Treichel AM, Hamieh L, Nathan NR, et al. Phenotypic distinctions between mosaic forms of tuberous sclerosis complex. Genet Med. 2019;21(11):2594–2604. doi:10.1038/s41436-019-0520-3
  • Giannikou K, Lasseter KD, Grevelink JM, et al. Low-level mosaicism in tuberous sclerosis complex: prevalence, clinical features, and risk of disease transmission [published correction appears in Genet Med. 2021 Oct;23(10):2022]. Genet Med. 2019;21(11):2639–2643. doi:10.1038/s41436-019-0562-6
  • Northrup H, Aronow ME, Bebin EM, et al. Updated international Tuberous Sclerosis Complex diagnostic criteria and surveillance and management recommendations. Pediatr Neurol. 2021;123:50–66. doi:10.1016/j.pediatrneurol.2021.07.011
  • Mayer K, Ballhausen W, Leistner W, Rott HD. Three novel types of splicing aberrations in the tuberous sclerosis TSC2 gene caused by mutations apart from splice consensus sequences. BBA-MOL BASIS DIS. 2000;1502:495–507. doi:10.1016/s0925-4439(00)00072-7
  • Abdelwahed M, Touraine R, Ben-Rhouma B, et al. A novel de novo splicing mutation c.1444-2A>T in the TSC2 gene causes exon skipping and premature termination in a patient with tuberous sclerosis syndrome. IUBMB Life. 2019;71(12):1937–1945. doi:10.1002/iub.2134
  • Jiangyi W, Gang G, Guohai S, et al. Germline mutation of TSC1 or TSC2 gene in Chinese patients with bilateral renal angiomyolipomas and mutation spectrum of Chinese TSC patients. Aging. 2020;12(1):756–766. doi:10.18632/aging.102654
  • Niu Y, Huang S, Xu P, et al. A case of tuberous sclerosis complex due to a novel splicing variant of TSC2 gene. Chin j med genet. 2021;38(6):553–556. doi:10.3760/cma.j.cn511374-20200211-00072
  • Qiu C, Li C, Tong X, et al. A novel TSC1 frameshift mutation c.1550_1551del causes tuberous sclerosis complex by aberrant splicing and nonsense-mediated mRNA degradation (NMD) simultaneously in a Chinese family. Mol Genet Genomic Med. 2020;8(10):e1410. doi:10.1002/mgg3.1410
  • Cariola F, Disciglio V, Valentini AM, et al. Characterization of a rare variant (c.2635-2A>G) of the MSH2 gene in a family with Lynch syndrome [published online ahead of print, 2018 Apr 24]. Int J Biol Markers. 2018:1724600818766496. doi:10.1177/1724600818766496
  • Ye Y, Zeng Y. Whole exome sequencing identifies a novel intron heterozygous mutation in TSC2 responsible for tuberous sclerosis complex. Sci Rep. 2019;9(1):4456. doi:10.1038/s41598-019-38898-9